Pardee Hospital Hendersonville : Discovery Health Tools : Medical Information and Health News

Medical

Diseases & Conditions
Lab Tests
Nutrition
Special Topics
Surgical Procedures
Symptoms

Health Tools

Anatomy Explorer
BMI Calculator
CME
Health IQ
Health Risk Assessments
Ready When You Are
Resources
Symptom Manager
Video Library

Communities

Allergies & Asthma
Alternative Medicine
Arthritis
Back Pain
Before Your Visit
Bone, Joint & Muscle
Cancer
Diabetes
Eye
Headache
Heart
HIV/AIDS
The New You
Parenting
Womens Health
More...

FDA Approves Gloucester Pharmaceuticals' ISTODAX(R) For Patients With Cutaneous T-cell Lymphoma
Gloucester Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved ISTODAX® (romidepsin) for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy. The approval of ISTODAX was based on objective disease response defined as the proportion of patients with confirmed complete response or partial response.